Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug-induced lung disease

J A Copper1

  • 1Pulmonary Section, Birmingham Veterans Administration Medical Center, Alabama, USA.

Advances in Internal Medicine
|January 1, 1997
PubMed
Summary

Drug-induced lung injury is a major clinical issue. Understanding the toxic versus therapeutic effects of drugs like bleomycin can help design better treatments for lung damage.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Purification of erythropoietin by ion-exchange chromatography.

Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)ยท1958
See all related articles

Area of Science:

  • Pulmonary medicine
  • Toxicology
  • Pharmacology

Background:

  • Drug-induced pulmonary reactions pose significant clinical challenges.
  • These reactions can limit the therapeutic use of essential medications.
  • Pulmonary drug toxicity serves as a model for broader lung injury research.

Purpose of the Study:

  • To investigate the mechanisms underlying drug-induced pulmonary toxicity.
  • To differentiate between the toxic and therapeutic actions of specific drugs.
  • To inform the development of safer and more effective therapeutic strategies.

Main Methods:

  • Review of existing literature on drug-induced lung injury.
  • Analysis of pharmacological data for drugs known to cause pulmonary reactions.
  • Comparative study of toxicological pathways versus therapeutic effects.

Main Results:

  • Certain drugs like bleomycin, carmustine, and amiodarone are associated with severe pulmonary reactions.
  • The precise mechanisms distinguishing toxic from therapeutic drug effects remain incompletely understood.
  • Identifying these mechanisms is crucial for mitigating adverse pulmonary events.

Conclusions:

  • Further research is needed to elucidate the dual mechanisms of drug action in the lungs.
  • Distinguishing toxic from therapeutic effects is key to designing improved drug therapies.
  • This knowledge will advance the treatment of drug-induced lung injury and other lung diseases.

Related Experiment Videos